104 related articles for article (PubMed ID: 14766663)
1. Montelukast in RSV-bronchiolitis.
Bisgaard H
Am J Respir Crit Care Med; 2004 Feb; 169(4):542-3. PubMed ID: 14766663
[No Abstract] [Full Text] [Related]
2. Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings?
Szefler SJ; Simoes EA
Am J Respir Crit Care Med; 2003 Feb; 167(3):290-1. PubMed ID: 12554617
[No Abstract] [Full Text] [Related]
3. Montelukast in respiratory syncytial virus postbronchiolitis.
López-Andreu JA; Cortell-Aznar I; Ruiz-García V
Am J Respir Crit Care Med; 2004 Jun; 169(11):1255; author reply 1255-6. PubMed ID: 15161615
[No Abstract] [Full Text] [Related]
4. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis.
Bisgaard H;
Am J Respir Crit Care Med; 2003 Feb; 167(3):379-83. PubMed ID: 12406832
[TBL] [Abstract][Full Text] [Related]
5. Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis.
Proesmans M; Sauer K; Govaere E; Raes M; De Bilderling G; De Boeck K
Acta Paediatr; 2009 Nov; 98(11):1830-4. PubMed ID: 19659463
[TBL] [Abstract][Full Text] [Related]
6. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
Bisgaard H; Flores-Nunez A; Goh A; Azimi P; Halkas A; Malice MP; Marchal JL; Dass SB; Reiss TF; Knorr BA
Am J Respir Crit Care Med; 2008 Oct; 178(8):854-60. PubMed ID: 18583576
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.
Peng WS; Chen X; Yang XY; Liu EM
Pediatr Allergy Immunol; 2014 Mar; 25(2):143-50. PubMed ID: 24118637
[TBL] [Abstract][Full Text] [Related]
8. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation.
Kim CK; Choi J; Kim HB; Callaway Z; Shin BM; Kim JT; Fujisawa T; Koh YY
J Pediatr; 2010 May; 156(5):749-54. PubMed ID: 20171653
[TBL] [Abstract][Full Text] [Related]
9. [Leukotriene and respiratory syncytial virus].
Zhang WX; Li CC
Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):109-10. PubMed ID: 23527973
[No Abstract] [Full Text] [Related]
10. Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.
Wu SH; Chen XQ; Kong X; Yin PL; Dong L; Liao PY; Wu JM
World J Pediatr; 2016 Feb; 12(1):88-95. PubMed ID: 25846070
[TBL] [Abstract][Full Text] [Related]
11. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood.
Lu S; Hartert TV; Everard ML; Giezek H; Nelsen L; Mehta A; Patel H; Knorr B; Reiss TF
Pediatr Pulmonol; 2016 Dec; 51(12):1382-1392. PubMed ID: 27152482
[TBL] [Abstract][Full Text] [Related]
12. Effect of interventions during acute respiratory syncytial virus bronchiolitis on subsequent long term respiratory morbidity.
Khoshoo V; Ross G; Edell D
Pediatr Infect Dis J; 2002 May; 21(5):468-72. PubMed ID: 12150194
[No Abstract] [Full Text] [Related]
13. Use of montelukast in the treatment of early childhood wheezing from clinical experience with three cases.
Ng DK; Law AK; Chau KW; Chan HK
Respirology; 2000 Dec; 5(4):389-92. PubMed ID: 11192552
[TBL] [Abstract][Full Text] [Related]
14. Do systemic corticosteroids improve acute outcomes in infants with RSV bronchiolitis?
Smith J; Salinas R
J Okla State Med Assoc; 2008 Jan; 101(1):14. PubMed ID: 18390234
[No Abstract] [Full Text] [Related]
15. Colchicine for respiratory syncytial virus bronchiolitis.
Altschuler EL
Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183646
[No Abstract] [Full Text] [Related]
16. Antibiotics in RSV bronchiolitis: still no evidence of effect.
Kneyber MC; Kimpen JL
Eur Respir J; 2007 Jun; 29(6):1285. PubMed ID: 17540793
[No Abstract] [Full Text] [Related]
17. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial.
Tahan F; Ozcan A; Koc N
Eur Respir J; 2007 Jan; 29(1):91-7. PubMed ID: 17050564
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization.
Chen CH; Lin YT; Yang YH; Wang LC; Lee JH; Kao CL; Chiang BL
Pediatr Allergy Immunol; 2008 Mar; 19(2):166-72. PubMed ID: 18257904
[TBL] [Abstract][Full Text] [Related]
19. Ribavarin in ventilated respiratory syncytial virus bronchiolitis: a randomized, placebo-controlled trial.
Khoshoo V; Edell D
Am J Respir Crit Care Med; 2000 Jul; 162(1):333-4. PubMed ID: 10903266
[No Abstract] [Full Text] [Related]
20. Respiratory syncytial virus disease: update on treatment and prevention.
Krilov LR
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
